Table 1 Correlation of MTA1 expression and clinicopathological features of MPM
From: MTA1 promotes metastasis of MPM via suppression of E-cadherin
| Characteristics | All patients | MTA1 expression | P | ||
|---|---|---|---|---|---|
| Low | High | χ2 | |||
| N | 65 | 25 | 40 | ||
| Sex | 0.455 | 0.559 | |||
| Male | 35 | 12 | 23 | ||
| Female | 30 | 13 | 17 | ||
| Age (years) | 0.842 | 0.040 | |||
| <60 | 27 | 10 | 17 | ||
| ≥60 | 38 | 15 | 23 | ||
| Histology | 0.038 | 6.524 | |||
| Epithelioid | 20 | 13 | 7 | ||
| Sarcomatoid | 25 | 7 | 18 | ||
| Biphasic | 20 | 5 | 15 | ||
| TNM stagea | 0.003 | 8.990 | |||
| I/II | 29 | 17 | 12 | ||
| III/IV | 36 | 8 | 28 | ||
| Lymph node Metastasis | 0.001 | 11.714 | |||
| Yes | 38 | 8 | 30 | ||
| No | 27 | 17 | 10 | ||
| Distant Metastasis | <0.001 | 14.562 | |||
| Yes | 35 | 6 | 29 | ||
| No | 30 | 19 | 11 | ||